NewsRoom Articles - Page 78 of 207

ThursdayJan 26, 2023 9:45 am

MetAlert, Inc. (MLRT) Planned Acquisition of TrakTec LLC Adds Superior Radio Frequency-Based Tracking Technology to Portfolio of Location-Based Solutions

MetAlert recently announced the planned acquisition of TrakTec LLC, a Florida-based leader in location awareness technology for consumer and business applications The acquisition is expected to add several products to MetAlert’s existing suite of products, one of which is an RFID and Bluetooth-enabled tracking technology called SafetyNet(R) The SafetyNet Tracking System comprises the SafetyNet Bracelets that patients wear, and a receiver-antenna combo used by police departments and first responders The Chelmsford Police Department in Massachusetts recently reported it had successfully located a missing senior citizen with dementia because of its participation in the SafetyNet program The department has, over time,…

ThursdayJan 26, 2023 9:00 am

Silo Pharma Inc. (NASDAQ: SILO) Provides Update on UCSF Psylocibin Clinical Trial

SILO recently provided status update on its sponsored clinical trial with UCSF examining psilocybin’s effects on inflammation Targeted patient populations from study may provide support for development and use of psilocybin as a therapeutic to treat inflammatory conditions Data collection from all study groups expected by April 2023 SILO additionally evaluating its ketamine formulation through its partnership agreement with Zylö Therapeutics Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company that fuses traditional medicine with psychedelics, recently provided a progress update on its sponsored clinical trial with the University of California, San Francisco (“UCSF”) examining the effect of psilocybin on…

WednesdayJan 25, 2023 11:11 am

New Study Finds More than 30% of Patients Use Cannabis for Chronic Pain

With more than 30 states allowing some form of cannabis, millions of Americans now have access to the drug in either medical or recreational markets. Over the past decade, research has shown that cannabis has potential as a treatment for conditions such as chronic pain without the side effects typically seen in pharmaceuticals. As a result, dozens of states have launched medical markets that allow patients with qualifying medical conditions to purchase and use legal cannabis for medical purposes. A recent study from the University of Michigan has revealed that slightly more than one-third of adults with chronic pain have…

TuesdayJan 24, 2023 12:17 pm

Toddlers, Infants Risk Severe Outcomes When Faced with Multiple Infections

A study conducted by researchers at Corewell Health East has revealed that toddlers and infants have higher chances of experiencing severe health outcomes in the face of the so-called “tripledemic,” which is comprised of flu, RSV and COVID. Three years after COVID-19 first reared its ugly head, new research found that young patients face the risk of severe health outcomes after being infected by multiple respiratory viruses. The investigators, led by Dr. Amit Bahl, found that although omicron cases made up the bulk of hospital admissions for those between the ages of 0 and 17, they weren’t as likely to…

TuesdayJan 24, 2023 9:00 am

HeartBeam Inc. (NASDAQ: BEAT) Combats Rising Heart Disease Numbers by Leading Out in Heart-Attack Detection Space

Rates of cardiovascular risk factors, disease and heart attacks projected to increase significantly HeartBeam offers a personal, portable and easy-to-use heart-attack detection solution “Our HeartBeam AIMI and HeartBeam AIMIGo solutions will transform the way patients and doctors detect heart attacks,” states CEO With heart disease consistently being the leading cause of death in the United States (https://ibn.fm/kDLwz), companies such as HeartBeam (NASDAQ: BEAT) that are focusing on solutions are gaining both attention and support. As a cardiac technology company, HeartBeam is leading the way in identifying heart attacks by developing a personal, portable and easy-to-use heart-attack detection solution. HeartBeam’s efforts…

MondayJan 23, 2023 12:39 pm

Researchers Find That Nutraceuticals May Be Useful in Preventing and Treating Cancer

The American Cancer Society Journals estimates that there will be 1.9 million additional cancer diagnoses and 609,820 million cancer deaths this year. The deadly disease affects tens of millions of people globally and causes millions of deaths across the world every year. Consequently, researchers are always looking for safer and more effective ways of preventing, detecting, and treating all kinds of cancers. Researchers from India’s Tata Memorial Center have found evidence showing that nutraceuticals, which are food extracts that have health benefits on top of their nutritional value, may have promise in the prevention and treatment of cancer. The team…

MondayJan 23, 2023 12:00 pm

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Developing Innovative Inhaled NanoAb Therapeutics for Multiple Indications, Including COVID-19

Current monoclonal antibody therapies less effective against emerging COVID-19 variants BiondVax is developing an inhaled nanosized antibody (NanoAb) therapy for COVID-19 with human clinical Phase 1/2a results anticipated in 2023 The global monoclonal antibodies market was valued at $185.5 billion in 2021 and is projected to grow at a CAGR of 11.3% due to the rising prevalence of chronic diseases and demand for biologics The biologics market size was valued at $366.5 billion in 2021 and is expected to reach $719.94 billion by 2030 According to a new study, new COVID-19 subvariants have become dominant in recent months, rendering some…

MondayJan 23, 2023 9:45 am

MetAlert, Inc. (MLRT) In Strong Position Entering 2023 According to CEO Patrick Bertagna

MetAlert’s CEO, Patrick Bertagna, while appearing in an interview presented by Sequire Spotlight and hosted by Carmel Fisher, expressed his optimism for the new year while also sharing the company’s recent progress He discussed the company’s core objective- increasing the quality of life, and longevity of people living with Alzheimer’s, dementia, and autism (“ADA”) Bertagna also hinted at potential acquisitions by the company, attributing it to extensive efforts over the past couple of years to clean up its balance sheet He noted that as MetAlert’s revenue per user continues to grow, its margins will increase, ultimately placing the company in…

FridayJan 20, 2023 10:47 am

Stem Cell Therapy Holds Promise in Future Cancer Care

Cancer is the second leading cause of death in the United States after heart disease, accounting for an estimated 602,350 deaths in 2020 and 608,570 deaths in 2021. Although we still don’t know exactly what causes normal cells to become cancerous, scientists have narrowed down several risk factors and developed various treatments to prolong the lives of cancer patients. These treatments include surgery, radiation, and chemotherapy or immunotherapy; these treatments are usually meant to rid the patient’s body of cancer cells. We know that the cancer develops when something goes wrong during the cell division process where damaged cells and…

ThursdayJan 19, 2023 11:58 am

New Research Suggests HRT May Reduce Alzheimer’s Risk in Women

Women make up nearly two-thirds of the people who suffer from Alzheimer’s in the United States. They account for almost 4 million of the more than 6 million patients aged 65 and over who live with Alzheimer's in the country; they also have a one-in-five risk of developing the neurological condition at 65. Researchers from Alzheimer’s Research UK have now discovered that hormone replacement therapy (HRT) may be able to lower women’s risk of developing Alzheimer’s in their lifetimes. Past studies have determined that a gene called APOE4 may increase an individual’s risk of Alzheimer’s disease. In this new observational…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

MetAlert, Inc. (MLRT) Planned Acquisition of TrakTec LLC Adds Superior Radio Frequency-Based Tracking Technology to Portfolio of Location-Based Solutions

Silo Pharma Inc. (NASDAQ: SILO) Provides Update on UCSF Psylocibin Clinical Trial

New Study Finds More than 30% of Patients Use Cannabis for Chronic Pain

Toddlers, Infants Risk Severe Outcomes When Faced with Multiple Infections

HeartBeam Inc. (NASDAQ: BEAT) Combats Rising Heart Disease Numbers by Leading Out in Heart-Attack Detection Space

Researchers Find That Nutraceuticals May Be Useful in Preventing and Treating Cancer

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Developing Innovative Inhaled NanoAb Therapeutics for Multiple Indications, Including COVID-19

MetAlert, Inc. (MLRT) In Strong Position Entering 2023 According to CEO Patrick Bertagna

Stem Cell Therapy Holds Promise in Future Cancer Care

New Research Suggests HRT May Reduce Alzheimer’s Risk in Women

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search